E
Medicenna Therapeutics Corp. MDNAF
$0.7212 -$0.0228-3.07%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -21.46% -14.87% 74.23% -181.91% -31.79%
Total Depreciation and Amortization 59.26% 118.92% 428.57% 0.00% 0.00%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 420.21% -191.17% -96.40% 4,198.06% 134.44%
Change in Net Operating Assets 146.48% -220.45% 213.02% -215.52% 52.24%
Cash from Operations 38.29% -141.90% 52.66% -21.44% -1.23%
Capital Expenditure 100.00% 93.39% -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 100.00% 93.39% -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 89.66% -95.19% -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 100.00% -- -- -- --
Cash from Financing 163.33% -96.61% -- -- --
Foreign Exchange rate Adjustments 503.25% -370.51% 55.66% -28.19% 1,471.15%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 91.95% -127.99% 484.68% -22.67% 1.39%
Weiss Ratings